Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect
Authors:
- 6 July 2009
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 23 (8) , 959-960
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Sorafenib-induced erythema multiformeJournal of the American Academy of Dermatology, 2007
- Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorClinical and Experimental Dermatology, 2006
- Safety and Pharmacokinetics of the Dual Action Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor, BAY 43-9006, in Patients with Advanced, Refractory Solid TumorsClinical Cancer Research, 2005
- BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and AngiogenesisCancer Research, 2004